Fair Value of Financial Instruments - Schedule of Quantitative Information and Assumptions Pertaining To The Fair Value Measurement of The Level 3 Inputs (Details) $ in Thousands	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Fair Value, Option, Quantitative Disclosures [Line Items]
Contingent consideration liabilities	$ 0	$ 2,700
Level 3
Fair Value, Option, Quantitative Disclosures [Line Items]
Contingent consideration liabilities	0	2,700
1095 commercialization milestone | Level 3
Fair Value, Option, Quantitative Disclosures [Line Items]
Contingent consideration liabilities	$ 0	$ 1,800
1095 commercialization milestone | Level 3 | Probability of success and sales targets | Probability adjusted discounted cash flow model
Fair Value, Option, Quantitative Disclosures [Line Items]
Liability measurement input	0	0.40
1095 commercialization milestone | Level 3 | Discount rate | Probability adjusted discounted cash flow model
Fair Value, Option, Quantitative Disclosures [Line Items]
Liability measurement input		0.041
Net sales targets – AZEDRA and 1095 | Level 3
Fair Value, Option, Quantitative Disclosures [Line Items]
Contingent consideration liabilities	$ 0	$ 900
Net sales targets – AZEDRA and 1095 | Level 3 | Probability of success and sales targets | Monte Carlo simulation
Fair Value, Option, Quantitative Disclosures [Line Items]
Liability measurement input	0
Net sales targets – AZEDRA and 1095 | Level 3 | Probability of success and sales targets | Monte Carlo simulation | Minimum
Fair Value, Option, Quantitative Disclosures [Line Items]
Liability measurement input		0
Net sales targets – AZEDRA and 1095 | Level 3 | Probability of success and sales targets | Monte Carlo simulation | Maximum
Fair Value, Option, Quantitative Disclosures [Line Items]
Liability measurement input		0.40
Net sales targets – AZEDRA and 1095 | Level 3 | Discount rate | Monte Carlo simulation
Fair Value, Option, Quantitative Disclosures [Line Items]
Liability measurement input		0.15